435 related articles for article (PubMed ID: 12419832)
61. Association between glutathione S-transferase T1, M1, and P1 genotypes and the risk of colorectal cancer.
Cong N; Liu L; Xie Y; Shao W; Song J
J Korean Med Sci; 2014 Nov; 29(11):1488-92. PubMed ID: 25408579
[TBL] [Abstract][Full Text] [Related]
62. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
63. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop DT; Primrose J; Bingham SA
Carcinogenesis; 2007 Apr; 28(4):875-82. PubMed ID: 17082176
[TBL] [Abstract][Full Text] [Related]
64. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
Lemos MC; Cabrita FJ; Silva HA; Vivan M; Plácido F; Regateiro FJ
Carcinogenesis; 1999 Jul; 20(7):1225-9. PubMed ID: 10383893
[TBL] [Abstract][Full Text] [Related]
65. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
[TBL] [Abstract][Full Text] [Related]
66. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
67. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D
Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698
[TBL] [Abstract][Full Text] [Related]
68. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
Figueroa JD; Malats N; García-Closas M; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Lan Q; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N
Carcinogenesis; 2008 Oct; 29(10):1955-62. PubMed ID: 18632753
[TBL] [Abstract][Full Text] [Related]
69. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
70. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
[TBL] [Abstract][Full Text] [Related]
71. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
72. Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer.
Steinbrecher A; Rohrmann S; Timofeeva M; Risch A; Jansen E; Linseisen J
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):135-43. PubMed ID: 20056632
[TBL] [Abstract][Full Text] [Related]
73. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
74. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
[TBL] [Abstract][Full Text] [Related]
75. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
Nakajima T; Aoyama T
Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
[TBL] [Abstract][Full Text] [Related]
76. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
77. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
Vineis P; Veglia F; Garte S; Malaveille C; Matullo G; Dunning A; Peluso M; Airoldi L; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen JP; Kaaks R; Boeing H; Trichopoulou A; Palli D; Crosignani P; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Gonzalez CA; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Riboli E; Autrup H
Ann Oncol; 2007 Jul; 18(7):1230-42. PubMed ID: 17496311
[TBL] [Abstract][Full Text] [Related]
78. Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Caballero M; Cruellas F; Raya A; Dicenta M; Corbella J
Cancer Lett; 2002 Dec; 187(1-2):95-101. PubMed ID: 12359356
[TBL] [Abstract][Full Text] [Related]
79. Aromatic DNA adducts and number of lung cancer risk alleles in Map-Ta-Phut Industrial Estate workers and nearby residents.
Peluso M; Srivatanakul P; Jedpiyawongse A; Sangrajrang S; Munnia A; Piro S; Ceppi M; Boffetta P; Godschalk RW; van Schooten FJ
Mutagenesis; 2013 Jan; 28(1):57-63. PubMed ID: 22987024
[TBL] [Abstract][Full Text] [Related]
80. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland.
Little J; Sharp L; Masson LF; Brockton NT; Cotton SC; Haites NE; Cassidy J
Int J Cancer; 2006 Nov; 119(9):2155-64. PubMed ID: 16823842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
